Welcome to our dedicated page for Art Technology Acquisition Cor news (Ticker: ARTC), a resource for investors and traders seeking the latest updates and insights on Art Technology Acquisition Cor stock.
News related to Art Technology Acquisition Corp. (ARTC) centers on its activities as a blank check company listed on the Nasdaq Global Market. The company has publicly announced the pricing of its initial public offering of units, each consisting of one Class A ordinary share and a fraction of a redeemable warrant, and the expected listing of its Class A ordinary shares and warrants under the symbols ARTC and ARTCW once they trade separately.
Investors following ARTC news can track updates on its capital-raising process, including information about the initial public offering, the structure of its units, and any options granted to underwriters to purchase additional units. Because Art Technology Acquisition Corp. is a special purpose acquisition company, future news may focus on its search for a suitable merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
The company has indicated a primary focus on identifying potential business combination targets in the technology, art, financial services, and investment banking sectors, while retaining the flexibility to consider opportunities in other industries. News coverage can therefore include announcements about potential or completed transactions in these areas, as well as regulatory milestones such as the effectiveness of its registration statement with the U.S. Securities and Exchange Commission.
By monitoring this ARTC news page, readers can review company-issued press releases and other public announcements that describe the progress of Art Technology Acquisition Corp. from its initial public offering through any subsequent business combination process.
Art Technology Acquisition Corp (NASDAQ:ARTCU / ARTC) priced an initial public offering of 22,000,000 units at $10.00 per unit for gross proceeds of $220,000,000. Units begin trading on January 6, 2026 on Nasdaq Global Market under ARTCU; separate Class A shares and warrants are expected to list as ARTC and ARTCW once separated. Each unit includes one Class A share and one-fourth of a redeemable warrant exercisable at $11.50. Closing is expected on or about January 7, 2026, and the underwriter has a 45-day option to purchase up to 3,300,000 additional units.
The company is a blank-check vehicle focused on targets in technology, art, financial services, and investment banking; Clear Street is sole book-running manager.
AdaptHealth Corp. (NASDAQ: AHCO) has announced the appointment of Greg Belinfanti to its Board of Directors, representing One Equity Partners. Belinfanti brings extensive board experience, having served on various healthcare-related boards, including Arthrocare (NASDAQ: ARTC). Brad Coppens, the previous OEP designee, will remain an independent director. Chairman Richard Barasch expressed appreciation for OEP's support and welcomed Belinfanti's expertise, which aims to strengthen the board's leadership and strategic direction.